Background: PnPP-19 is a 19-amino-acid synthetic peptide previously described as a novel
drug for the treatment of erectile dysfunction.
Objective: The aim of this work was to evaluate the physicochemical properties of cationic transfersomes
containing PnPP-19 and the skin permeation of free PnPP-19 and PnPP-19-loaded transfersomes.
Methods: Three different liposomal preparation methods were evaluated. Cationic transfersomes contained
egg phosphatidyl choline: stearylamine (9:1 w/w) and Tween 20 (84.6:15.4 lipid:Tween, w/w).
Lipid concentration varied from 20 to 40 mM. We evaluated the entrapment percentage, mean diameter,
zeta potential and stability at 4 °C of the formulations. The skin permeation assays were performed with
abdominal human skin using Franz diffusion cell with 3 cm2 diffusion area at 32 °C and a fluorescent
derivative of the peptide, containing 5-TAMRA, bound to PnPP-19 C-terminal region, where an extra
lysine was inserted.
Results: Our results showed variable entrapment efficiencies, from 6% to 30%, depending on the preparation
method and the lipid concentration used. The reverse phase evaporation method using a total lipid
concentration equal to 40 mM led to the best entrapment percentage (30.2 + 4.5%). Free PnPP-19 was
able to permeate skin at a rate of 10.8 ng/cm2/h. However, PnPP-19 was specifically hydrolyzed by skin
proteases, generating a fragment of 15 amino acid residues. Encapsulated PnPP-19 permeated the skin at
a rate of 19.8 ng/cm2/h.
Conclusion: The encapsulation of PnPP-19 in cationic transfersomes protected the peptide from degradation,
favoring its topical administration.